Haemonetics Corporation Other Asset Impairment Charges
Haemonetics Corporation (HAE) reported Other Asset Impairment Charges of $0 for the 3-month period ending 2020-12-26, per its 10-Q filed 2021-02-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherAssetImpairmentCharges · last filed 2021-02-02
- Haemonetics Corporation other asset impairment charges for the quarter ending 2020-12-26 was $0.00, a 100.00% decline year-over-year.
- Haemonetics Corporation other asset impairment charges for the quarter ending 2020-09-26 was $0.00.
- Haemonetics Corporation other asset impairment charges for the quarter ending 2020-06-27 was $1.03M, a 97.89% decline year-over-year.
- Haemonetics Corporation other asset impairment charges for the quarter ending 2019-12-28 was $1.88M.
- Haemonetics Corporation other asset impairment charges for fiscal 2019 was $21.17M, a 990.67% increase from fiscal 2018.
- Haemonetics Corporation other asset impairment charges for fiscal 2018 was $1.94M, a 97.35% decline from fiscal 2017.
- Haemonetics Corporation other asset impairment charges for fiscal 2017 was $73.35M, a 24.56% decline from fiscal 2016.
- Haemonetics Corporation other asset impairment charges for fiscal 2016 was $97.23M, a 1686.99% increase from fiscal 2015.
| Period end | Other Asset Impairment Charges 3 month | Other Asset Impairment Charges 3 month as first filed | Other Asset Impairment Charges 6 month | Other Asset Impairment Charges 6 month as first filed | Other Asset Impairment Charges 9 month | Other Asset Impairment Charges 9 month as first filed | Other Asset Impairment Charges 12 month | Other Asset Impairment Charges 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-12-26 | $0.00 10-Q · filed 2021-02-02 | $0.00 derived: sum of 2 quarters · filed 2021-02-02 | $1.03M 10-Q · filed 2021-02-02 | |||||
| 2020-09-26 | $0.00 10-Q · filed 2020-11-04 | $1.03M 10-Q · filed 2020-11-04 | ||||||
| 2020-06-27 | $1.03M 10-Q · filed 2020-08-04 | |||||||
| 2019-12-28 | $1.88M 10-Q · filed 2021-02-02 | $1.88M derived: sum of 2 quarters · filed 2021-02-02 | $50.60M 10-Q · filed 2021-02-02 | $71.77M derived: sum of 4 quarters · filed 2021-02-02 | ||||
| 2019-09-28 | $0.00 10-Q · filed 2020-11-04 | $48.72M 10-Q · filed 2020-11-04 | $69.89M derived: sum of 3 quarters · filed 2020-11-04 | $69.89M derived: sum of 4 quarters · filed 2020-11-04 | ||||
| 2019-06-29 | $48.72M 10-Q · filed 2020-08-04 | $69.89M derived: sum of 2 quarters · filed 2020-08-04 | $69.89M derived: sum of 3 quarters · filed 2020-08-04 | $69.89M derived: sum of 4 quarters · filed 2020-08-04 | ||||
| 2019-03-30 | $21.17M derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-22 | $21.17M derived: sum of 2 quarters · filed 2020-02-04 | $21.17M derived: sum of 3 quarters · filed 2020-02-04 | $21.17M 10-K · filed 2019-05-22 | ||||
| 2018-12-29 | $0.00 10-Q · filed 2020-02-04 | $0.00 derived: sum of 2 quarters · filed 2020-02-04 | $0.00 10-Q · filed 2020-02-04 | $21.17M 10-Q · filed 2019-02-05 | $1.94M derived: sum of 4 quarters · filed 2020-02-04 | |||
| 2018-09-29 | $0.00 10-Q · filed 2019-11-01 | $0.00 10-Q · filed 2019-11-01 | $21.17M 10-Q · filed 2018-11-06 | $1.94M derived: sum of 3 quarters · filed 2019-11-01 | $1.94M derived: sum of 4 quarters · filed 2019-11-01 | |||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-06 | $21.17M 10-Q · filed 2018-08-07 | $1.94M derived: sum of 2 quarters · filed 2019-08-06 | $1.94M derived: sum of 3 quarters · filed 2019-08-06 | $1.94M derived: sum of 4 quarters · filed 2019-08-06 | |||
| 2018-03-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-22 | $1.94M derived: sum of 2 quarters · filed 2019-05-22 | $1.94M derived: sum of 3 quarters · filed 2019-05-22 | $1.94M 10-K · filed 2019-05-22 | ||||
| 2017-12-30 | $0.00 10-Q · filed 2019-02-05 | $0.00 derived: sum of 2 quarters · filed 2019-02-05 | $0.00 10-Q · filed 2018-02-06 | $71.83M derived: sum of 4 quarters · filed 2019-05-22 | ||||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 | $71.83M derived: sum of 3 quarters · filed 2019-05-22 | $72.04M derived: sum of 4 quarters · filed 2019-05-22 | ||||
| 2017-07-01 | $0.00 10-Q · filed 2018-08-07 | $71.83M derived: sum of 2 quarters · filed 2019-05-22 | $72.04M derived: sum of 3 quarters · filed 2019-05-22 | $72.78M derived: sum of 4 quarters · filed 2019-05-22 | ||||
| 2017-04-01 | $71.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-22 | $72.04M derived: sum of 2 quarters · filed 2019-05-22 | $72.78M derived: sum of 3 quarters · filed 2019-05-22 | $73.35M 10-K · filed 2019-05-22 | $58.59M 10-K · filed 2017-05-24 | |||
| 2016-12-31 | $210.00K 10-Q · filed 2018-02-06 | $949.00K derived: sum of 2 quarters · filed 2018-02-06 | $1.52M 10-Q · filed 2018-02-06 | $3.41M 10-Q · filed 2017-02-06 | $14.90M derived: sum of 4 quarters · filed 2018-05-23 | |||
| 2016-10-01 | $739.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-07 | $2.50M 10-Q · filed 2017-11-07 | $14.69M derived: sum of 3 quarters · filed 2018-05-23 | |||||
| 2016-07-02 | $1.77M 10-Q · filed 2017-08-07 | $13.95M derived: sum of 2 quarters · filed 2018-05-23 | ||||||
| 2016-04-02 | $12.18M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-23 | $97.23M 10-K · filed 2018-05-23 | $92.39M 10-K · filed 2016-06-01 | |||||
| 2015-12-26 | $85.05M 10-Q · filed 2017-02-06 | |||||||
| 2015-03-28 | $5.44M 10-K · filed 2017-05-24 | |||||||
| 2014-03-29 | $1.71M 10-K · filed 2016-06-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |